Investor Stock List
Ranked #331 of 8,699 institutional investors

Baker Bros. Advisors LP

New York, NY

$19.97B
US stock portfolio at live prices · today +$71.9M (+0.36%)
Market closed. Prices as of Nov 20, 8:41 AM ET
Value at quarter end (Q3 2026)
$20.99B
Change from Q2 2026
+$1.10B (+5.55%)
Positions
75 · 4 new, 6 sold out
Filed
Nov 16, 2026

Not counted in the ranking: $55.5M of convertible notes and other principal-amount securities. $788M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
INCY 17.8%ONC 17.7%KOD 10.7%RVMD 8.49%INSM 6.36%
StockSharesValue, live% of portfoliovs Q2 2026
INCY Incyte Corporation30,762,652$3.56B17.8%Unchanged
ONC BeOne Medicines AG8,832,335$3.53B17.7%Added +0%
KOD Kodiak Sciences Inc.21,860,941$2.14B10.7%Added +10%
RVMD Revolution Medicines, Inc.10,637,318$1.70B8.49%Reduced −7%
INSM Insmed Incorporated8,796,111$1.27B6.36%Unchanged
KYMR Kymera Therapeutics, Inc.8,657,242$1.03B5.18%Unchanged
MDGL Madrigal Pharmaceuticals, Inc.2,143,131$850M4.26%Unchanged
ACAD Acadia Pharmaceuticals Inc.42,912,904$755M3.78%Unchanged
RYTM Rhythm Pharmaceuticals, Inc.5,604,483$655M3.28%Unchanged
PRAX Praxis Precision Medicines, Inc.1,753,198$545M2.73%Unchanged
GRAL GRAIL, Inc.4,028,614$422M2.11%Unchanged
SMMT Summit Therapeutics Inc.32,786,348$347M1.74%Unchanged
ABCL AbCellera Biologics Inc.33,012,139$346M1.73%Unchanged
CELC Celcuity Inc.4,815,792$271M1.36%Reduced −39%
REPL Replimune Group, Inc.11,045,336$212M1.06%Unchanged
EWTX Edgewise Therapeutics, Inc.3,701,719$152M0.76%Unchanged
IDYA IDEAYA Biosciences, Inc.5,010,030$131M0.66%Unchanged
IMVT Immunovant, Inc.2,770,377$90.1M0.45%Reduced −49%
ARWR Arrowhead Pharmaceuticals, Inc.1,709,053$74.6M0.37%Reduced −14%
DNTH Dianthus Therapeutics, Inc.852,164$72.3M0.36%Unchanged
CLDX Celldex Therapeutics, Inc.2,564,984$71.7M0.36%Added +117%
DNLI Denali Therapeutics Inc.3,734,336$68.0M0.34%Unchanged
NRIX Nurix Therapeutics, Inc.4,658,556$63.4M0.32%Unchanged
RLAY Relay Therapeutics, Inc.2,826,783$45.0M0.23%Unchanged
MIRM Mirum Pharmaceuticals, Inc.445,975$42.6M0.21%Unchanged
ELVN Enliven Therapeutics, Inc.905,191$42.0M0.21%Unchanged
GLUE Monte Rosa Therapeutics, Inc.4,345,736$38.7M0.19%Unchanged
XNCR Xencor, Inc.1,102,106$37.5M0.19%Unchanged
RAPP Rapport Therapeutics, Inc.1,547,090$36.5M0.18%Unchanged
STOK Stoke Therapeutics, Inc.1,313,999$35.4M0.18%Reduced −61%
BCYC Bicycle Therapeutics plc10,885,357$33.2M0.17%Unchanged
PRLD Prelude Therapeutics Incorporated10,123,824$33.0M0.17%Unchanged
IONS Ionis Pharmaceuticals, Inc.1,023,864$27.9M0.14%Reduced −50%
DSGN Design Therapeutics, Inc.2,988,144$27.8M0.14%Added +12%
IRON Disc Medicine, Inc.349,657$26.6M0.13%Unchanged
GPCR Structure Therapeutics Inc.1,432,529$24.5M0.12%Unchanged
TRDA Entrada Therapeutics, Inc.5,072,730$23.5M0.12%Unchanged
NGNE Neurogene Inc.991,691$22.7M0.11%Unchanged
TRAX First Tracks Biotherapeutics, Inc.472,932$21.0M0.11%New
JBIO Jade Biosciences, Inc.1,230,426$18.5M<0.1%Unchanged
ABSI Absci Corporation2,134,803$17.4M<0.1%Unchanged
AKTS Aktis Oncology, Inc.996,351$16.3M<0.1%Unchanged
TSHA Taysha Gene Therapies, Inc.4,004,756$15.1M<0.1%Unchanged
GENB Generate Biomedicines, Inc.1,423,602$14.8M<0.1%Unchanged
XENE Xenon Pharmaceuticals Inc.370,208$13.9M<0.1%Unchanged
PBLS Parabilis Medicines, Inc.500,000$13.8M<0.1%Unchanged
DBVT DBV Technologies S.A.1,461,425$13.8M<0.1%Unchanged
RCUS Arcus Biosciences, Inc.844,816$13.3M<0.1%Unchanged
DYN Dyne Therapeutics, Inc.813,449$13.0M<0.1%Unchanged
TECX Tectonic Therapeutic, Inc.607,788$12.8M<0.1%Unchanged
CYTK Cytokinetics, Incorporated211,267$10.9M<0.1%Unchanged
SERA Sera Prognostics, Inc.5,498,170$10.4M<0.1%Unchanged
CTMX CytomX Therapeutics, Inc.4,975,826$10.2M<0.1%Unchanged
AVLN Avalyn Pharma Inc.350,000$10.0M<0.1%Unchanged
BNTX BioNTech SE119,743$9.7M<0.1%Unchanged
SCTX Scribe Therapeutics Inc.688,691$9.1M<0.1%New
EVMN Evommune Inc1,234,794$8.9M<0.1%Added +46%
LBRX LB Pharmaceuticals Inc200,000$8.0M<0.1%Unchanged
NTLA Intellia Therapeutics, Inc.829,053$7.9M<0.1%Reduced −11%
FRNM Freenome, Inc.794,908$7.9M<0.1%New
TNGX Tango Therapeutics, Inc.333,333$7.6M<0.1%Unchanged
MPLT MapLight Therapeutics, Inc.1,166,763$7.5M<0.1%Added +220%
FTH Faeth Therapeutics, Inc.803,425$7.0M<0.1%Reduced −38%
QTTB Q32 Bio Inc.547,945$4.6M<0.1%New
CERS Cerus Corporation2,333,155$4.4M<0.1%Reduced −64%
TARA Protara Therapeutics, Inc.1,843,795$4.4M<0.1%Added +90%
AVTX Avalo Therapeutics, Inc.550,000$3.7M<0.1%Unchanged
EIKN Eikon Therapeutics, Inc.555,555$2.6M<0.1%Unchanged
VTVT vTv Therapeutics Inc.148,314$2.4M<0.1%Unchanged
IMNM Immunome, Inc.55,306$919K<0.1%Unchanged
SANA Sana Biotechnology, Inc.310,483$540K<0.1%Unchanged
TCRX TScan Therapeutics, Inc.2,784,792$397K<0.1%Unchanged
TYRA Tyra Biosciences, Inc.10,607$209K<0.1%Unchanged
SKYE Skye Bioscience, Inc.196,905$155K<0.1%Unchanged
ALGS Aligos Therapeutics, Inc.83,055$104K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
VRDN Viridian Therapeutics, Inc.2,383,025$74.9M
VSTM Verastem, Inc.2,499,338$17.1M
SGMT Sagimet Biosciences Inc.952,996$9.2M
ALMS Alumis Inc.2,012,500$8.7M
WVE Wave Life Sciences, Inc.822,638$2.2M
SION Sionna Therapeutics, Inc.400,000$1.2M